NEW DELHI: Adar Poonawalla, CEO of vaccine major Serum Institute of India (SII), on Sunday urged other countries to be patient as they wait for the supplies of Covid-19 vaccine Covishield, as it has been directed to prioritise the needs of India.
Apart from making efforts to meet the requirements of India, the company is also trying to balance the needs of the rest of the world, he added. “We are trying our best,” Poonawalla tweeted.